Axsome Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $7.26 billion, with shareholders equity totaling $105.43 million.
The company employs approximately 925 people and operates in the Health sector, within the Pharmaceutical Products industry.
Over the past 12 months, Axsome Therapeutics Inc. reported $865.27 million in revenue, generating net income of $-157.29 million.
Key financial metrics include a P/E ratio of -46.17, a price-to-book (P/B) ratio of 68.88, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker AXSM.